Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine PK/PD for Postpartum Depression and Pain After Cesarean Delivery
NCT06767566Phase 1Recruiting
- Sponsor
- University of Utah
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ketamine in pain and postpartum depression (PPD) (2 arms), sponsored by University of Utah. Primary endpoint: Maternal ketamine area under the curve. Started Mar 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
painpostpartum depression (PPD)
Beyond the preview
Go deeper on NCT06767566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06767566.